Market:

Diabetes is one of the most pervasive and expensive diseases in the world. One in three Americans have prediabetes, yet 80% don’t know they have it. The cost of allowing prediabetes to go undetected and develop into Type 2 diabetes is enormous. In the U.S., $1 in every $4 spent on healthcare is for diabetes care. Employers pay $8,000 per year for each employee with diabetes. Preventing diabetes with early detection provides an ROI over 10 years of $55,000 per employee.

Technology:

DigiScan™, ViBo Health’s system under development, will transform early detection of prediabetes and disrupt the current diagnosis model, which misses 80% of cases. The tabletop scanner will be installed where consumers already go: high-traffic locations such as pharmacies, gyms, university campuses and workplaces. The platform uses a combination of magnetic resonance spectroscopy and predictive algorithms to measure and map a customer’s health, providing dynamic, actionable recommendations.

Advantages:

• Accurate: detects multiple biomarkers
• Accessible: Available in easy-to-access locations
• User-friendly: No need for specialists
• Quick: 10-second finger scan
• Inexpensive: No cost to user

Development Stage:

• Prototype

Patents:

• Filed: G. Travish, “METHODS AND APPARATUS FOR BENCHTOP METABOLITE PROFILING IN SITU,” PCT/US22/40369 priority date 08/17/2021
• Filed: G. Travish, “Health Trackers for Autonomous Targeting of Tissue Sampling Sites,” USPTO application No. 17848154, filed 06/23/2022
• Licensed: Jianping Hu and Louis Bouchard, “MINIATURIZED MAGNETIC RESONANCE PROBE” PCT/US13/50161.
• Licensed: Cyril Mangenot, Giovanni Toso and Carolina Tienda Herrero, “Array Antenna Having a Radiation Pattern with a Controlled Envelope, and Method of Manufacturing it”, EP2697865B, 12 April 2011.

Contact:

Website: www.vibo.health
Phone: (310) 435-7172
Email: info@vibo.health
Social Media: LinkedIn | Crunchbase

Back to Top